BackC4 Therapeutics Overview

C4 Therapeutics Selling, General & Admin

Selling, General & Admin expenses for CCCC.

Quarterly SG&A Expenses

$7.53M
↓ 19.29% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$34.40M
↓ 12.7% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin